IT software products company Quick Heal Technologies announced Q2FY23 results: Q2FY23: Revenue at Rs 101 crore EBIDTA at Rs 28.4 crore PAT at Rs 22.2 crore H1FY23 Revenue at Rs162 crore EBITDA at Rs 29.4 crore PAT at Rs 22.3 crore Dr. Kailash Katkar, Managing Director and Chief Executive Officer, Quick Heal Technologies Limited, said, “We continue to deliver strong growth in our revenues in the enterprise segment. Q2 marks 9th straight quarter delivering YoY growth for the Enterprise segment. This solidifies our belief in the business we incubated from scratch years ago and has crossed Rs 100 crore revenues in TTM basis. We have taken focussed initiatives and interventions towards our consumer segment which is degrowing at 11% to bring it back to the growth path. We have been investing heavily into our R&D; and S&M; for achieving our vision of growing multifold in the years to come,” he added. Mr. Navin Sharma, Chief Financial Officer, Quick Heal Technologies Limited, said, “The need for cybersecurity is fundamentally increasing owing to the developments happening across the globe. We are overlooking bright opportunities and investing heavily in R&D; and S&M; to address the core and evolving needs of the customers. R&D; investments for the quarter stands at 30% while the S&M; stands at 25%. Our balance sheet remains strong with zero debt and cash and cash equivalents of Rs 338 crore as on 30th September 2022. We are committed to driving shareholder value by growing profitability across both of our segments and driving solid Unlevered Cash Flow and constantly rewarding our shareholders though buyback and dividend distribution programs.” Result PDF
IT Software Products company Quick Heal Technologies declares Q3FY22 result: Quick Heal Technologies Third Quarter Revenue Grows 14%, Enterprise segment continues to grow in double digits Revenue at Rs 796 mln up 14% EBIDTA at Rs 205 mln up 24% PAT at Rs 143 mln up 6% EPS at Rs 2.45 up 17% Continues to be a debt free company Dr. Kailash Katkar, Managing Director and Chief Executive Officer, Quick Heal Technologies Limited, said, “We delivered a robust third quarter in terms of revenue, subscribers, profitability and cash flow which is a testament to our team’s strong execution. Our continued commitment to secure our customers’ ever-increasing online footprint helped us add 818 thousand new subscribers. The growth in enterprise segment has been promising and we expect the momentum to continue in the coming quarters. In line with our strategy to boost market share, we continue to invest in R&D; and strengthen leadership team that will enable us to launch next-generation solutions in the coming quarters,” he added. Mr. Navin Sharma, Chief Financial Officer, Quick Heal Technologies Limited, said, “We delivered solid results in Q3, as continued strong demand for our cybersecurity products across our diversified global go-to-market channels, coupled with our focus on operational discipline, resulted in 14% Y-o-Y growth in Revenue and 24% Y-o-Y growth in EBITDA. In line with our continued focus on R&D; and innovation, we spent 27% of revenues as R&D; during the quarter. Our balance sheet remains strong with zero debt and cash and cash equivalents of Rs 3,275 mln as on 31st December 2021. We are committed to driving shareholder value by growing profitability across both of our segments and driving solid Unlevered Cash Flow.” Result PDF
Conference Call with Quick Heal Technologies Management and Analysts on Q2FY22 Performance and Outlook. Listen to the full earnings transcript.